| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/12/2002 | US20020127674 Nucleotide sequences coding polypeptide for use in human therapeutics, and diagnostics, cosmetics and nutrition |
| 09/12/2002 | US20020127668 Polypeptide for use in the diagnosis and treatment of cancer, nervous system and vessicular transport disorders |
| 09/12/2002 | US20020127657 Proteins for use in the diagnossi and treatment cancer and autoimmune diseases |
| 09/12/2002 | US20020127656 DNA repair polypeptides and methods of use |
| 09/12/2002 | US20020127655 Nucleic acids and proteins of a rat ganglioside GM1-specific alpha 1-2 fucosyltransferase and uses thereof |
| 09/12/2002 | US20020127653 Hematopoietic signaling factor |
| 09/12/2002 | US20020127652 Polypeptide for use in the treatment of mammalian sexual disorders |
| 09/12/2002 | US20020127651 Nucleotide seqences coding transport proteins for use in the diagnosis, treatment and prevention of infection, schock and inflammatory defects |
| 09/12/2002 | US20020127648 Novel human C5a-like receptor |
| 09/12/2002 | US20020127647 ATP-binding cassette transporter-like molecules and uses thereof |
| 09/12/2002 | US20020127645 Secretory immunoglobulin produced by single cells and methods for making and using same |
| 09/12/2002 | US20020127643 Nucleotide sequences coding membrane proteins for use in human therapeutics and diagnostics |
| 09/12/2002 | US20020127642 Porcine leptin protein, antisense and antibody |
| 09/12/2002 | US20020127640 Pancreas-derived plasminogen activator inhibitor |
| 09/12/2002 | US20020127639 Nucleotide sequences coding protein for use in the treatment of diabetes, hyperlipidemia and eating disorders |
| 09/12/2002 | US20020127637 Nucleotide sequences coding protein for use in the diagnosis and treatment of cell proliferation defects |
| 09/12/2002 | US20020127635 Method of complexing a protein by the use of a dispersed system and proteins thereof |
| 09/12/2002 | US20020127634 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 09/12/2002 | US20020127615 Protein for use in the treatment of autoimmune, skin, kidney, liver and blood disorders |
| 09/12/2002 | US20020127613 Isolated nucleic acid molecules which encode GAGE genes and uses thereof |
| 09/12/2002 | US20020127612 Cell proliferation polypeptide for use in the diagnosis and treatment of tumors |
| 09/12/2002 | US20020127602 Troponin I polypeptide fragments and uses thereof |
| 09/12/2002 | US20020127600 Uncoupling protein for use in the treatment of body weight defects |
| 09/12/2002 | US20020127596 murF2 |
| 09/12/2002 | US20020127595 Endostatin; for use as a contraceptive and in cancer treatment |
| 09/12/2002 | US20020127594 Nucleotide sequences coding polypeptide for use in the treating and diagnosing cell proliferative defects |
| 09/12/2002 | US20020127584 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/12/2002 | US20020127583 Detecting prion protein in sample; obtain tissue sample, incubate with binding protein, detect bound complex |
| 09/12/2002 | US20020127579 Breast carcinoma-associated gene |
| 09/12/2002 | US20020127576 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of cancer, nervous system and blood disorders |
| 09/12/2002 | US20020127572 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents |
| 09/12/2002 | US20020127568 Nucleotide sequences coding protein for use in the treatment of cellular proliferation, differentiation, cardiovascular, liver, pain, metabolic, brain, blood disorders, hematopoietic and platelet disorders |
| 09/12/2002 | US20020127567 Nucleotide sequence coding transport protein for use in the diagnosis and treatment of liver disorders |
| 09/12/2002 | US20020127553 Apoptin-associating protein |
| 09/12/2002 | US20020127548 Methods for detecting mutations associated with hypertrophic cardiomyopathy |
| 09/12/2002 | US20020127542 Pharmaceutical compositions for treating tumour diseases |
| 09/12/2002 | US20020127540 Detecting modulators of bone morphogenic activities; obtain cells, incubate with modulator, monitor expression of reporter molecules, compare to control |
| 09/12/2002 | US20020127289 Use of bowman birk inhibitor for the treatment of multiple sclerosis and other autoimmune diseases |
| 09/12/2002 | US20020127247 Modified clostridial neurotoxins with altered biological persistence |
| 09/12/2002 | US20020127246 Use of herpes vectors for tumor therapy |
| 09/12/2002 | US20020127245 Canine coronavirus S gene and uses therefor |
| 09/12/2002 | US20020127244 Fractionating a mixture of polyethylene glycol(PEG)-protein adducts comprising partitioning the PEG/protein adducts in a PEG-containing aqueous biphasic system |
| 09/12/2002 | US20020127243 Administering dietary supplement comprising soybean, mushroom and mung bean or extracts to ameliorate at least one effect of malignancy or viral infection |
| 09/12/2002 | US20020127239 LipL32 polypeptide is useful for inducing an immune response to a pathogenic spirochete in a patient |
| 09/12/2002 | US20020127238 Utilizing a modified HIV-1 envelope protein or fragment or DNA encoding a modified HIV-1 envelope protein or fragment, wherein modified protein having a HIV-1 envelope protein V2 region deletion |
| 09/12/2002 | US20020127236 Contacting the sample containing an antibody specific for isolated and purified antigenically-active blood group antigen protein or peptide to allow the formation of an immune complex; and detecting the immune complex |
| 09/12/2002 | US20020127235 Identification and molecular characterization of proteins, expressed in the Ixodes ricinus salivary glands |
| 09/12/2002 | US20020127233 Method for inhibiting inflammation in immune privileged sites using Fas ligand fragments |
| 09/12/2002 | US20020127232 Activating alpha 2-macroglobulin by incubation with a nucleophilic compound to form nucleophile-activated alpha 2-macroglobulin, removing excess of nucleophilic compound, incubating activated alpha-2 macroglobulin with biomolecule |
| 09/12/2002 | US20020127231 Extracellular domains of a heterodimeric protein operatively linked to immunoglobulin heavy and light chain polypeptides |
| 09/12/2002 | US20020127227 Antagonist monoclonal antibodies (mAb) that bind to the RHAMM (receptor for hyaluronic acid mediated motility) receptor; useful for preventing proliferative disease states in a mammal |
| 09/12/2002 | US20020127226 Tyrosine phosphatase receptor protein- tenascin ligand complex |
| 09/12/2002 | US20020127225 Nucleic acid and amino acid sequences of an annexin binding protein useful in diagnosis, prevention, treatment of cancer, immune disorder and neurological disorders |
| 09/12/2002 | US20020127223 Binding antibodies or antiboy-comparable with affinity for body cells not meant to be affected by chemotherapeutical drug directly to an antidote or to carriers such as proteins, or microbody carriers such as liposomes, erythroctes |
| 09/12/2002 | US20020127222 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 09/12/2002 | US20020127221 Urocortin proteins and uses thereof |
| 09/12/2002 | US20020127220 Use of bacterial phage associated lysing enzymes for treating streptococcal infections of the upper respiratory tract- |
| 09/12/2002 | US20020127219 A polypeptide selected from lysosomal enzymes and lysosomal enzyme activators, consist of at least one introduced glycosylation site as compared to a corresponding parent enzyme or activator |
| 09/12/2002 | US20020127217 A polynucleotides which identify and encode Phosphatidylinositol 4,5-bisphosphate 5-phosphatase (polypeptide) |
| 09/12/2002 | US20020127216 Placental alkaline phosphatase and a gel-forming material for stimulating proliferation of fibroblasts |
| 09/12/2002 | US20020127215 Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections |
| 09/12/2002 | US20020127214 RAC-protein kinase as therapeutic agent or in diagnostics |
| 09/12/2002 | US20020127213 Administering to patient a therapeutically effective amount of both an N-alkyl derivative of deoxynojirimycin and a glucocerebrosidase enzyme to alleviate or inhibit glycolipid storage disease; Gaucher's disease |
| 09/12/2002 | US20020127212 Use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses |
| 09/12/2002 | US20020127211 Increasing or facilitating absorption of minerals from diet using enteral nutritional composition which includes lactobacilli |
| 09/12/2002 | US20020127210 Transplants for myocardial scars |
| 09/12/2002 | US20020127209 Tripeptide of intracellular tyrosine-based activation motifs (ITAM) mediates trafficking of targets phagocytosed via Fc gamma RIIA to the lysosomal compartment |
| 09/12/2002 | US20020127206 Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections |
| 09/12/2002 | US20020127204 Improvements in or relating to protection against intracellular infection |
| 09/12/2002 | US20020127203 Polypeptide having phenylacetyl-coenzyme a ligase activity which has been isolated from culture; for production of penicillin |
| 09/12/2002 | US20020127202 Compounds and compositions for delivering active agents |
| 09/12/2002 | US20020127201 Contacting T cell with agent which binds to cytokine receptor gamma chain and stimulates an intracellular signal in T cell resulting in T cell proliferation, with proviso that agent does not consist of natural interleukin-2 |
| 09/12/2002 | US20020127200 Canine interleukin-5 proteins, canine interleukin-5 nucleic acid molecules |
| 09/12/2002 | US20020127199 Novel nucleic acids and polypeptides |
| 09/12/2002 | US20020127198 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/12/2002 | US20020127188 Composition for pulmonary administration comprising a drug and a hydrophobic amino acid |
| 09/12/2002 | US20020127186 Use of electrolytes (lons in solution) to suppress charging of inhalation aerosols |
| 09/12/2002 | US20020127138 Comprises albumen lysozyme from fowls and glycine for spraying into barns and surroundings |
| 09/12/2002 | US20020124852 Method of treating diabetes mellitus in a patient |
| 09/12/2002 | DE10109855A1 Polypeptide eines p53-Protein-spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung Polypeptide of a p53 protein specific murine alpha / beta T-cell receptor nucleic acids encoding these, and their use |
| 09/12/2002 | DE10109854A1 Polypeptide eines hdm2-Protein spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung Polypeptides of hdm2 protein specific murine alpha / beta T-cell receptor nucleic acids encoding these, and their use |
| 09/12/2002 | DE10109813A1 Tumor-Peptidantigen aus humanem mdm2 Proto-Onkogen Tumor antigen peptide from human MDM2 proto-oncogene |
| 09/12/2002 | DE10109466A1 Verfahren und Mittel zur Modifikation humaner Angiogenese Method and means for modification of human angiogenesis |
| 09/12/2002 | DE10059595A1 Proteine und den Proteinen zugrundeliegende DNA-Sequenzen mit Funktion bei Entzündungsereignissen Proteins and the proteins underlying DNA sequences function in inflammatory events |
| 09/12/2002 | CA2743731A1 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 09/12/2002 | CA2445018A1 Tumour peptide antigen produced from human mdm2 proto-oncogene |
| 09/12/2002 | CA2445013A1 Polypeptides of an hdm2 protein-specific murine alpha/beta t-cell receptor, nucleic acids encoding these and their use |
| 09/12/2002 | CA2445004A1 Polypeptides of a p53 protein-specific murine alpha/beta t-cell receptor, nucleic acids encoding these and their use |
| 09/12/2002 | CA2442524A1 Matrix stabilized enzyme crystals and methods of use |
| 09/12/2002 | CA2442396A1 Method and formula for anti-tumor and anti-matastatic effect |
| 09/12/2002 | CA2441476A1 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 09/12/2002 | CA2440358A1 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses |
| 09/12/2002 | CA2440141A1 Compounds and methods for the treatment of urogenital disorders |
| 09/12/2002 | CA2440092A1 Protein c variants |
| 09/12/2002 | CA2439941A1 Secreted proteins |
| 09/12/2002 | CA2439934A1 Use of protein histidine phosphatase |
| 09/12/2002 | CA2439933A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 09/12/2002 | CA2439929A1 Modified protamine with reduced immunogenicity |
| 09/12/2002 | CA2439926A1 Modified human granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity |
| 09/12/2002 | CA2439832A1 Cyclosporins for the treatment of respiratory diseases |